Anti-glycan monoclonal antibodies: Basic research and clinical applications

Author(s)

K.M. Gillmann, J. S. Temme, S. Marglous, C.E. Brown & J. C. Gildersleeve

Sources

Current Opinion in Chemical Biology 2023, 74:102281 https://doi.org/10.1016/j.cbpa.2023.102281

Anti-glycan monoclonal antibodies have essential applications in human health and basic research. Therapeutic antibodies that recognize cancer- or pathogen-associated glycans have been investigated in numerous clinical trials, resulting in two FDA-approved biopharmaceuticals. Anti-glycan antibodies are also utilized to diagnose, prognosticate, and monitor disease progression, as well as to study the biological roles and expression of glycans.
897glycopedia.png
High-quality anti-glycan mAbs are still in limited supply, highlighting the need for new technologies for anti-glycan antibody discovery. This review discusses anti-glycan monoclonal antibodies with applications to basic research, diagnostics, and therapeutics, focusing on recent advances in mAbs targeting cancer- and infectious disease-associated glycans.
897_bis.png

Latest news

 The carbohydrate 3D structure-prediction tools (builders) at GLYCAM-Web (glycam.org) are widely used for generating experimentally-consistent...

Glycosylation, the key reaction in synthetic glycochemistry, remains entirely unpredictable due to its complex mechanism...

The ‘taste of sweetness’ is one of the most iconic and universally recognised human sensory...

recognize sialic acid residues on cell surfaces. Pathogens and tumor cells exploit Siglecs to evade...